Anavex Life Sciences Corp (AVXL)

[Investor2014]

We need to separate completely securing a patent and regulatory approval. The latter doesn't require a patent.

The examples may well hold true, at least that is certainly the intention, but they are not required to reflect a tried and tested scenario. If such an example or one very similar to it is later established, the idea is that the patent teaches that kind of use and thus makes it easier to enforce the patent in an infringement situation.

So definitely I think there is course to be encouraged by the patent and examples, but we should not expect the example to be some kind of true life insight into the progress of patients in the current trial.